• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Regenerative Medicine Market in the US 2014-2018 - Product Image Special Offer Sale Banner

Regenerative Medicine Market in the US 2014-2018

  • ID: 2887246
  • June 2014
  • Region: United States
  • 100 pages
  • TechNavio
Special Offer Banner
10%
OFF
Offer ends 02nd Jan 2020

FEATURED COMPANIES

  • Aastrom Biosciences Inc.
  • BioCardia Inc.
  • Fibrocell Science Inc.
  • InVivo Therapeutics
  • Medtronic Inc.
  • Organogenesis Inc.
  • MORE

About Regenerative Medicine

Regenerative medicine is the branch of medicine which uses therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. This branch of medicine focuses on repairing, replacing, or regenerating the damaged cells of the body and thus represents a paradigm shift in healthcare treatment. The two main technologies used in regenerative medicine are tissue engineering and stem cell technology.

The analysts forecast the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018.

Covered in this Report
The Regenerative Medicine market in the US can be divided into 11 segments: Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology, Plastic and Reconstructive Surgery, Osteoarthritis, Trauma, General Surgery, Hernia Repair, Burns, Urology, and Urogynecology.

The report, the Regenerative Medicine Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. It focuses on the Regenerative Medicine market in the US landscape and its growth prospects in the coming years. READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aastrom Biosciences Inc.
  • BioCardia Inc.
  • Fibrocell Science Inc.
  • InVivo Therapeutics
  • Medtronic Inc.
  • Organogenesis Inc.
  • MORE

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Regenerative Medicine Market in the US by Application 2013
07.2 Orthopedic Tendon and Ligament market in the US
07.2.1 Market Size and Forecast
07.3 Chronic and Acute Wounds market in the US
07.3.1 Market Size and Forecast
07.4 Cardiology market in the US
07.4.1 Market Size and Forecast
07.5 Plastic and Reconstructive Surgery market in the US
07.5.1 Market Size and Forecast
07.6 Breast Reconstruction market in the US
07.6.1 Market Size and Forecast
07.7 Osteoarthritis market in the US
07.7.1 Market Size and Forecast
07.8 Trauma market in the US
07.8.1 Market Size and Forecast
07.9 General Surgery market in the US
07.9.1 Market Size and Forecast
07.10 Hernia Repair market in the US
07.10.1 Market Size and Forecast
07.11 Burns market in the US
07.11.1 Market Size and Forecast
07.12 Urology market in the US
07.12.1 Market Size and Forecast
07.14 Urogynecology market in the US
07.14.1 Market Size and Forecast
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
15.1 Market Share Analysis 2013
15.2 Other Prominent Vendors
16. Key Vendor Analysis
16.1 Baxter International Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Business Segmentation
16.1.4 Business Strategy
16.1.5 Revenue by Business Segmentation
16.1.6 Revenue by Geographical Segmentation
16.1.7 Key Developments
16.1.8 SWOT Analysis
16.1.9 Strengths
16.1.10 Weaknesses
16.1.11 Opportunities
16.1.12 Threats
16.2 Johnson and Johnson Ltd.
16.2.1 Key Facts
16.2.2 Business Overview
16.2.3 Business Segmentation by Revenue 2013
16.2.4 Business Segmentation by Revenue 2012 and 2013
16.2.5 Sales by Geography
16.2.6 Business Strategy
16.2.7 Key Information
16.2.8 SWOT Analysis
16.2.9 Strengths
16.2.10 Weaknesses
16.2.11 Opportunities
16.2.12 Threats
16.3 Kinetic Concepts Inc.
16.3.1 Key Facts
16.3.2 Business Overview
16.3.3 Business Segmentation
16.3.4 Revenue by Business Segmentation
16.3.5 Revenue Segmentation by Geography
16.3.6 Business Strategy
16.3.7 Key Developments
16.3.8 SWOT Analysis
16.3.9 Strengths
16.3.10 Weaknesses
16.3.11 Opportunities
16.3.12 Threats
16.4 Medtronic Inc.
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Business Segmentation
16.4.4 Revenue by Business Segmentation
16.4.5 Revenue Comparison 2012 and 2013
16.4.6 Revenue Segmentation by Geography
16.4.7 Business Strategy
16.4.8 Key Developments
16.4.9 SWOT Analysis
16.4.10 Strengths
16.4.11 Weaknesses
16.4.12 Opportunities
16.4.13 Threats
16.5 Stryker Corp.
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Business Segmentation
16.5.4 Revenue by Business Segmentation
16.5.5 Revenue Comparison 2012 and 2013
16.5.6 Sales by Geography
16.5.7 Business Strategy
16.5.8 Key Developments
16.6 SWOT Analysis
16.6.1 Strengths
16.6.2 Weaknesses
16.6.3 Opportunities
16.6.4 Threats
17. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Regenerative Medicine Market in the US 2013-2018 (US$ million)
Exhibit 3: Regenerative Medicine Market in the US by Application 2013
Exhibit 5: Orthopedic Tendon and Ligament Market in the US 2013-2018 (US$ million)
Exhibit 6: Chronic and Acute Wounds Market in the US 2013-2018 (US$ million)
Exhibit 7: Cardiology Market in the US 2013-2018 (US$ million)
Exhibit 8: Plastic and Reconstructive Surgery Market in the US 2013-2018 (US$ million)
Exhibit 9: Breast Reconstruction Market in the US 2013-2018 (US$ million)
Exhibit 10: Osteoarthritis Market in the US 2013-2018 (US$ million)
Exhibit 11: Trauma Market in the US 2013-2018 (US$ million)
Exhibit 12: General Surgery Market in the US 2013-2018 (US$ million)
Exhibit 13: Hernia Repair Market in the US 2013-2018 (US$ million)
Exhibit 14: Burns Market in the US 2013-2018 (US$ million)
Exhibit 15: Urology Market in the US 2013-2018 (US$ million)
Exhibit 16: Urogynecology Market in the US 2013-2018 (US$ million)
Exhibit 17: Baxter International Inc. : Business Segmentation
Exhibit 18: Baxter International Inc.: Revenue by Business Segmentation 2013
Exhibit 19: Baxter International Inc.: Revenue by Geographical Segmentation 2013
Exhibit 20: Johnson and Johnson Ltd.: Business Segmentation by Revenue 2013
Exhibit 21: Business Segmentation by Revenue 2012 and 2013US$ billions
Exhibit 22: Johnson and Johnson Ltd.: Sales by Geography 2013
Exhibit 23: Exhibit 1: Kinetic Concepts Inc.: Business Segmentation
Exhibit 24: Exhibit 2: Kinetic Concepts Inc.: Revenue by Business Segmentation 2013
Exhibit 25: Exhibit 4: Kinetic Concepts Inc.: Revenue Segmentation by Geography 2013
Exhibit 26: Exhibit 1: Medtronic Inc.: Business Segmentation
Exhibit 27: Exhibit 2: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 28: Exhibit 3: Medtronic Inc.: Revenue Comparison 2012 and 2013 (US$ million)
Exhibit 29: Exhibit 4: Medtronic Inc.: Revenue Segmentation by Geography 2013
Exhibit 30: Stryker Corp.,: Business Segmentation
Exhibit 31: Stryker Corp.: Revenue by Business Segmentation 2013
Exhibit 32: Stryker Corp.: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 33: Stryker Corp.: Revenue by Geographical Segmentation 2013

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aastrom Biosciences Inc.
  • BioCardia Inc.
  • Fibrocell Science Inc.
  • InVivo Therapeutics
  • Medtronic Inc.
  • Organogenesis Inc.
  • MORE

The author Announces the Publication of its Research Report - Regenerative Medicine Market in the US 2014-2018

The author recognizes the following companies as the key players in Regenerative Medicine Market in the US: Baxter International Inc., Johnson and Johnson Ltd., Kinetic Concepts Inc., Medtronic Inc., Stryker Corp., Aastrom Biosciences Inc., Acologix Inc., Advanced Cell Technology Inc., Arteriocyte Inc., Athersys Inc.,AvitaMedical Ltd., Bacterin International Inc., Bellicum Pharmaceuticals Inc., Bioactive Regenerative Therapeutics Inc., BioCardia Inc., BioLife Solutions Inc., CryoLife Inc., Cynata Therapeutics Inc., CytomedixInc., Cytori Therapeutics Inc., Fibrocell Science Inc., Forticell Bioscience Inc., GE Healthcare, Geron Corp., Histogenics, Humacyte Inc., Integra Life Sciences Holdings Corp. , InVivo Therapeutics, KenseyNash Corp., Kinetic Concepts Inc., MaxCyte Inc., Mesoblast Ltd., Nanofiber Solutions CTO, NeoStem Inc., Neuralstem Inc., Olympus Terumo Biomaterials Corp., Opexa Therapeutics Inc., Organogenesis Inc.,Osiris Therapeutics Inc., Osteotech Inc., Pluristem Therapeutics Inc., ReNeuron Group plc, RTI Biologics Inc., SanBio Inc., StemCells Inc., Tengion Inc., Thermo Fischer Scientific Inc., Tissue Genesis Inc., ViaCyteInc.

Commenting on the report, an analyst from The author ’s team said: “The Regenerative Medicine market in the US has witnessed a number of mergers and acquisitions by leading vendors in the past few years. Vendors are focusing on mergers and acquisitions to strengthen their global position and increase their commercial capabilities. For instance, in November 2012, Smith & Nephew acquired Healthpoint Biotherapeutics for US$782 million. Also, in January 2011, NeoStem acquired Progenitor Cell Therapy and in May 2011, Shire acquired Advanced BioHealing for US$750 million. These acquisitions have resulted in a better vendor product portfolio and have a positive impact on the growth of the market.”

According to the report, the Regenerative Medicine market in the US is driven by several factors, of which the increasing prevalence of degenerative diseases is one of the major drivers. Regenerative medicine offers the chance to find favorable therapies for chronic diseases. Stem cell therapies are increasingly being applied in various medical conditions as they help in restoring body functions and improving the quality of a patient's life. This increased application of stem cell therapies in various medical conditions is driving the growth of the Regenerative Medicine market in the US.

Further, the report states that one of the main challenges is the stringent regulatory approval process for regenerative products. Market participants need to gain prior approval from regulatory bodies before introducing new products in the market. As a result of this, vendors are unable to introduce new regenerative products in the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown

- Baxter International Inc.
- Johnson and Johnson Ltd.
- Kinetic Concepts Inc.
- Medtronic Inc.
- Stryker Corp.
- Aastrom Biosciences Inc.
- Acologix Inc.
- Advanced Cell Technology Inc.
- Arteriocyte Inc.
- Athersys Inc.
- AvitaMedical Ltd.
- Bacterin International Inc.
- Bellicum Pharmaceuticals Inc.
- Bioactive Regenerative Therapeutics Inc.
- BioCardia Inc.
- BioLife Solutions Inc.
- CryoLife Inc.
- Cynata Therapeutics Inc.
- CytomedixInc.
- Cytori Therapeutics Inc.
- Fibrocell Science Inc.
- Forticell Bioscience Inc.
- GE Healthcare
- Geron Corp.
- Histogenics
- Humacyte Inc.
- Integra Life Sciences Holdings Corp.
- InVivo Therapeutics
- KenseyNash Corp.
- Kinetic Concepts Inc.
- MaxCyte Inc.
- Mesoblast Ltd.
- Nanofiber Solutions CTO
- NeoStem Inc.
- Neuralstem Inc.
- Olympus Terumo Biomaterials Corp.
- Opexa Therapeutics Inc.
- Organogenesis Inc.
- Osiris Therapeutics Inc.
- Osteotech Inc.
- Pluristem Therapeutics Inc.
- ReNeuron Group plc
- RTI Biologics Inc.
- SanBio Inc.
- StemCells Inc.
- Tengion Inc.
- Thermo Fischer Scientific Inc.
- Tissue Genesis Inc.
- ViaCyteInc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S